MAKSCIENTIFIC, LLC

Organization

Watertown, MA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Process for making biologically active compounds and intermediates...
- Patent number 11,939,325
- Issue date Mar 26, 2024
- MAKSCIENTIFIC, LLC
- Alexandros Makriyannis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ABHD6 and dual ABHD6/MGL inhibitors and their uses
- Patent number 10,662,159
- Issue date May 26, 2020
- MAKSCIENTIFIC, LLC
- Alexandros Makriyannis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CB1 receptor antagonists and uses thereof
- Patent number 8,293,211
- Issue date Oct 23, 2012
- MAKScientific, LLC
- Alexandros Makriyannis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antiprotozoal ring-substituted phospholipids
- Patent number 8,097,752
- Issue date Jan 17, 2012
- MAKScientific, LLC
- Theodora Calogeropoulou
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
Novel Compounds for Treating Fibrosis and Inflammatory Conditions
- Publication number 20230234928
- Publication date Jul 27, 2023
- MAKScientific, LLC
- Alexandros Makriyannis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for Treating Cannabinoid Toxicity and Acute Cannabinoid O...
- Publication number 20220033393
- Publication date Feb 3, 2022
- MAKScientific, LLC
- Alexandros Makriyannis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process for Making Biologically Active Compounds and Intermediates...
- Publication number 20220024910
- Publication date Jan 27, 2022
- MAKScientific, LLC
- Alexandros Makriyannis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method for Treating a Neurodegenerative Event
- Publication number 20160136110
- Publication date May 19, 2016
- MAKSCIENTIFIC, LLC
- Alexandros Makriyannis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CB1 Receptor Antagonists and Uses Thereof
- Publication number 20130123229
- Publication date May 16, 2013
- MAKSCIENTIFIC, LLC
- Alexandros Makriyannis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

NIH Research Projectlast 12 months

processing...

Count: 13

Research Projects

Information Research Project
Lead Optimization of Peripheral CB1 Neutral Antagonists for Renal D...
- Application id 9680781
- Award notice date Sep 13, 2019
Information Research Project
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
- Application id 9357603
- Award notice date Aug 22, 2017
Information Research Project
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
- Application id 9201955
- Award notice date Sep 23, 2016
Information Research Project
NAAA Inhibitors as Anti-Inflammatory Agents
- Application id 8834187
- Award notice date Apr 1, 2015
Information Research Project
Cannabinergic Receptor Antagonists for Nicotine Addiction
- Application id 8713752
- Award notice date May 30, 2014
Information Research Project
New Drugs to Enhance Endocannabinoid Responses for Treating Excitot...
- Application id 7907545
- Award notice date Jan 6, 2011
Information Research Project
New Drugs to Enhance Endocannabinoid Responses for Treating Excitot...
- Application id 7672193
- Award notice date Aug 3, 2009
Information Research Project
New Drugs to Enhance Endocannabinoid Responses for Treating Excitot...
- Application id 7326276
- Award notice date Aug 27, 2007
Information Research Project
CB1 Receptor Antagonists in Drug Abuse
- Application id 6791036
- Award notice date Sep 29, 2004
Information Research Project
NOVEL AZETIDINE CB1 ANTAGONISTS
- Application id 7962740
Information Research Project
NOVEL CB1 RECEPTOR ANTAGONIST: PHASE II-271077424
- Application id 7329591
Information Research Project
NOVEL AZETIDINE CB1 ANTAGONISTS
- Application id 8014395
Information Research Project
Novel Azetidine CB1 Antagonists
- Application id 7660014

MAKSCIENTIFIC, LLC

Organization

Patents Grantslast 30 patents

Process for making biologically active compounds and intermediates...

ABHD6 and dual ABHD6/MGL inhibitors and their uses

CB1 receptor antagonists and uses thereof

Antiprotozoal ring-substituted phospholipids

Patents Applicationslast 30 patents

Novel Compounds for Treating Fibrosis and Inflammatory Conditions

Compounds for Treating Cannabinoid Toxicity and Acute Cannabinoid O...

Process for Making Biologically Active Compounds and Intermediates...

Method for Treating a Neurodegenerative Event

CB1 Receptor Antagonists and Uses Thereof

NIH Research Projectlast 12 months

Research Projects

Lead Optimization of Peripheral CB1 Neutral Antagonists for Renal D...

NAAA Inhibitors as Anti-inflammatory Agents, Phase II

NAAA Inhibitors as Anti-inflammatory Agents, Phase II

NAAA Inhibitors as Anti-Inflammatory Agents

Cannabinergic Receptor Antagonists for Nicotine Addiction

New Drugs to Enhance Endocannabinoid Responses for Treating Excitot...

New Drugs to Enhance Endocannabinoid Responses for Treating Excitot...

New Drugs to Enhance Endocannabinoid Responses for Treating Excitot...

CB1 Receptor Antagonists in Drug Abuse

NOVEL AZETIDINE CB1 ANTAGONISTS

NOVEL CB1 RECEPTOR ANTAGONIST: PHASE II-271077424

NOVEL AZETIDINE CB1 ANTAGONISTS

Novel Azetidine CB1 Antagonists